Faeth Therapeutics files initial beneficial ownership statement for Khosla Ventures VI, L.P
FTH•Form 3 filing discloses Khosla Ventures VI as a 10% owner
Faeth Therapeutics Form 3 filing disclosed Khosla Ventures VI as a 10% owner, reporting 2,632,232 shares of common stock held indirectly.
- Holdings were split between 1,643,349 shares held via Khosla Ventures VI, L.P. and 988,883 shares held via Khosla Ventures Seed D, L.P.
- The ownership statement was triggered on June 15, 2026.
